RNA Formulation Solutions

  1. Benchtop For Lipid Nanoparticle R&D And Pre-Clinical Development 12/18/2023

    Helix Biotech’s Nova™ Benchtop (BT) system is designed for lipid nanoparticle R&D and pre-clinical development – screen and optimize nanoparticle formulations quickly and with a versatile and scalable platform.

  2. in vivo-jetRNA®+ 9/14/2022

    Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
    in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry.

  3. Accelerating Gene Therapy With The HIT SCAN Platform 4/7/2025

    Battelle’s HIT SCAN™ platform accelerates gene therapy by using high-throughput methods to design, screen, and optimize polymer nanoparticles (PNPs) for effective, non-viral delivery.

     

  4. New Solutions For Large Molecule Analysis 6/16/2023

    Explore Biozen LC Portfolio

    With a new titanium BioTi™ biocompatible hardware to minimize priming, four particle platforms for optimal versatility and nine particle chemistries to maximize selectivity and sensitivity, Biozen UHPLC/HPLC columns are seamlessly designed to bring peace of mind to your analysis of biologics through:

    • Charge Variant Analysis
    • Aggregate Analysis
    • Peptide Mapping
    • Intact Mass Intact and Fragment Analysis
    • Glycan Analysis
    • Peptide Quantitation
    • Drug Antibody Ratio (DAR)
    • Oligonucleotide Characterization
  5. Plasmid DNA Manufacturing 1/31/2023

    As a critical starting material in the production of many advanced therapies including viral vectors and RNA vaccines, cell and gene therapy research at any scale requires plasmid DNA manufacturing. Our specialists provide custom plasmid production that fits your project specifications. To save time and accelerate your cell and gene therapy programs, we also offer off-the-shelf, premanufactured, High Quality viral vector packaging plasmids.

  6. Automated, Single-Use System For Clinical And Commercial LNP Production 7/21/2023

    The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.